US 7556926
Methods for screening insulin-sensitizing agents
granted A61KA61K31/7088A61P
Quick answer
US patent 7556926 (Methods for screening insulin-sensitizing agents) held by Takeda Pharmaceutical Company Limited expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7088, A61P, A61P3/04, A61P3/06